Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-023809

EVP, Global Sales & Marketing sold 34,160 shares at an average $5.02 ($171,616)

  • EVP, Global Sales & Marketing acquired 34,160 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ross Thomas M. · EVP, Global Sales & Marketing

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-05 Exercise or conversion : show line 1 in the form 10b5-1 +6,967 $2.14 $14,923 6,967 D
2023-04-05 Sale : show line 2 in the form 10b5-1 −6,967 $5.00 $34,835 0 D
2023-04-06 Exercise or conversion : show line 3 in the form 10b5-1 +27,193 $2.14 $58,247 27,193 D
2023-04-06 Sale : show line 4 in the form 10b5-1 −27,193 $5.03 $136,781 0 D
Open-market sales · 34,160 sh · avg $5.02 · $171,616

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-04-05 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −6,967 55,195 D
2023-04-06 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) −27,193 28,002 D
Loading xslF345X04/doc4.xml…